PE-backed SERB to buy BTG's specialty pharma business for $800m
Boston Scientific Corporation has agreed to sell BTG's specialty pharmaceuticals business for $800 million.
2 December 2020•2 mins read
Boston Scientific Corporation has agreed to sell BTG's specialty pharmaceuticals business for $800 million.
Walter Capital Partners takes significant stake in Quebec educational games maker Passe-Temps
7 hours ago · 1 min read
Truelink Capital’s GES buys CSG Creative from National Trade Productions
7 hours ago · 2 mins read
MPE Partners’ Intermatic adds outdoor lighting-control products maker Sun-Tech
7 hours ago · 2 mins read
Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage
7 hours ago · 1 min read
Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility
8 hours ago · 1 min read
FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push
8 hours ago · 1 min read
PE targets identity security as AI transforms threats: 6 deals
10 hours ago · 3 mins read
